sb 216763 has been researched along with Liver Cirrhosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, K; Hua, X; Ma, X; Wu, H; Xia, Q; Zhang, J; Zhou, T; Zhuang, S | 1 |
Abdel-Razek, W; Coant, N; Devière, J; Fasseu, M; Gandoura, S; Gustot, T; Lebrec, D; Lettéron, P; Lizard, G; Moreau, R; Ogier-Denis, E; Ouziel, R; Ragot, K; Simon-Rudler, M; Tellier, Z; Thabut, D | 1 |
2 other study(ies) available for sb 216763 and Liver Cirrhosis
Article | Year |
---|---|
Inhibition of GSK-3β induces AP-1-mediated osteopontin expression to promote cholestatic liver fibrosis.
Topics: Adolescent; Animals; Child; Disease Models, Animal; Female; Gene Expression Regulation; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Liver; Liver Cirrhosis; Male; Maleimides; Mice; Mice, Inbred C57BL; Osteopontin; Signal Transduction; Transcription Factor AP-1; Up-Regulation | 2018 |
Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
Topics: Adjuvants, Immunologic; Adult; Aged; Cells, Cultured; Female; Gene Expression Regulation, Enzymologic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hepatitis; Humans; Indoles; Interleukin-10; Interleukin-12; Lipopolysaccharides; Lithium Chloride; Liver Cirrhosis; Male; Maleimides; Middle Aged; Monocytes; Proto-Oncogene Proteins c-akt; Severity of Illness Index; Signal Transduction; Toll-Like Receptor 4 | 2011 |